Maravai LifeSciences Holdings Inc. (MRVI) is priced at $37.16 after the most recent trading session. At the very opening of the session, the stock price was $36.45 and reached a high price of $37.25, prior to closing the session it reached the value of $36.49. The stock touched a low price of $36.13.Recently in News on November 10, 2021, Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022. Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2021, together with other business updates. Highlights include:. You can read further details here
Maravai LifeSciences Holdings Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $63.55 on 08/23/21, with the lowest value was $25.32 for the same time period, recorded on 01/06/21.
Maravai LifeSciences Holdings Inc. (MRVI) full year performance was 41.35%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Maravai LifeSciences Holdings Inc. shares are logging -41.53% during the 52-week period from high price, and 57.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $23.62 and $63.55.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 763296 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Maravai LifeSciences Holdings Inc. (MRVI) recorded performance in the market was 32.48%, having the revenues showcasing -37.21% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 9.62B, as it employees total of 460 workers.
Market experts do have their say about Maravai LifeSciences Holdings Inc. (MRVI)
During the last month, 0 analysts gave the Maravai LifeSciences Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 45.52, with a change in the price was noted -2.45. In a similar fashion, Maravai LifeSciences Holdings Inc. posted a movement of -6.19% for the period of last 100 days, recording 1,601,471 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for MRVI is recording 1.94 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.92.
Technical breakdown of Maravai LifeSciences Holdings Inc. (MRVI)
Raw Stochastic average of Maravai LifeSciences Holdings Inc. in the period of last 50 days is set at 21.38%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 27.63%. In the last 20 days, the company’s Stochastic %K was 26.91% and its Stochastic %D was recorded 28.41%.
Bearing in mind the latest performance of Maravai LifeSciences Holdings Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 32.48%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -1.17%, alongside a boost of 41.35% for the period of the last 12 months. The shares increased approximately by -1.09% in the 7-day charts and went up by -9.89% in the period of the last 30 days. Common stock shares were lifted by -37.21% during last recorded quarter.